Last update :
28/04/2024
References   References 2340  
Type : Journal
Web link : http://www.cjhp-online.ca/index.php/cjhp/article/view/318

Research teams : Toronto - Sunnybrook Health Sciences Center
Authors : Walker S.E, Law S, Puodziunas A.
Title : Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Reference : Can J Hosp Pharm ; 58, 4: 212-222. 2005

Level of Evidence : 
Level of evidence B
Physical stability : 
Visual examination 
Chemical stability : 
High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)
Stability defined as 90% of the initial concentration
Other methods : 
PH measurement 
Comments : 
Degradation products identified

List of drugs
InjectionFolinate calcium Cytoprotective
Compatible 0,23 >> 0,95 mg/ml + InjectionIrinotecan 0,31 >> 0,65 mg/ml + Glucose 5%
Incompatible 3,55 >> 3,67 mg/ml + InjectionIrinotecan 0,34 >> 0,35 mg/ml + Glucose 5%
InjectionIrinotecan Anticancer drug
Compatible 0,31 >> 0,65 mg/ml + InjectionFolinate calcium 0,23 >> 0,95 mg/ml + Glucose 5%
Incompatible 0,34 >> 0,35 mg/ml + InjectionFolinate calcium 3,55 >> 3,67 mg/ml + Glucose 5%
Stability of mixtures
Glass Glucose 5% 23°C Not specified
Injection Folinate calcium 0,23 >> 0.95 mg/ml
Injection Irinotecan 0,31 >> 0,65 mg/ml
0.5 Hour

  Mentions Légales